Year: 2012
Type: article
Abstract: E ach year at the end of June, Thomson Reuters releases journal impact factors (IFs), a measure reflecting the average number of citations to articles published in each journal over the two previous years and generally accepted as a proxy for the relative importance of a journal among others serving a particular field. As discussed below, one can debate the wisdom of reliance on this particular citation metric, although Molecular Therapy has indeed benefited from many consecutive years of increases in the IF.
Source: Molecular Therapy
DOI: 10.1038/mt.2012.140
Authors: Robert M Frederickson, Malcolm K Brenner
Language: English
Subfield: Statistics, Probability and Uncertainty
Field: Decision Sciences
Domain: Social Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W2032160072